Optimal predictive probability designs for randomized biomarker-guided oncology trials

INTRODUCTION: Efforts to develop biomarker-targeted anti-cancer therapies have progressed rapidly in recent years. With efforts to expedite regulatory reviews of promising therapies, several targeted cancer therapies have been granted accelerated approval on the basis of evidence acquired in single-...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Zabor, Emily C., Kaizer, Alexander M., Pennell, Nathan A., Hobbs, Brian P.
Materyal Türü: Online Makale Metin
Dil:English
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2022
Konular:
Oncology
Online Erişim:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763994/
https://www.ncbi.nlm.nih.gov/pubmed/36561534
http://dx.doi.org/10.3389/fonc.2022.955056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763994/
https://www.ncbi.nlm.nih.gov/pubmed/36561534
http://dx.doi.org/10.3389/fonc.2022.955056

Benzer Materyaller